Nice to see Bioshares back they have always had a bit of a soft spot for Phylogica, their ratings dropped from Class A to B but I assume that is largely just as a result of having the past partners walk - more partners &/or advancing a deal to a later stage and obviously that will lift back up.
Interesting to see the efficiency hurdle covered - that was always a suspect on assumption as to why some of those earlier partnerships didn't progress but was never mentioned as such - nice to see a bit of clarity there.
Nice to see Bioshares back they have always had a bit of a soft...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
0.005(0.39%) |
Mkt cap ! $758.2M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.31 | $1.29 | $521.0K | 401.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 80931 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 37939 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |